DVA logo

DaVita (DVA) EBITDA

Annual EBITDA

$2.32 B
+$265.19 M+12.90%

December 31, 2023

Summary

Performance

1-Year Change

+12.9%

3-Year Change

+3.03%

5-Year Change

+9.13%

15-Year Change

-11%

DVA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.81%
DVA annual EBITDA is higher than 96.81% of companies in Healthcare sector

High & Low

All-time High

$2.76 B
DVA annual EBITDA is currently -15.83% below its historical high of $2.76 billion

3-Year Low

$2.06 B
DVA annual EBITDA is currently +12.90% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
DVA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 13, 2025
DVA next annual earnings announcement is scheduled for Feb 13, 2025

OtherDVAprofitabilitymetrics:

Annual Revenue

$12.14 B
DVA annual revenue is $12.14 billion

Annual Net Income

$691.53 M
DVA annual net profit is $691.53 million

Annual EBIT

$1.58 B
DVA annual earnings before interest & taxes is $1.58 billion

Annual EPS

$7.42
DVA annual earnings per share is $7.42

Quarterly EBITDA

$695.03 M
+$50.18 M+7.78%

September 30, 2024

Summary

Performance

3-Month Change

+7.78%

1-Year Change

+19.72%

3-Year Change

+19.72%

5-Year Change

+19.72%

DVA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.48%
DVA quarterly EBITDA is higher than 96.48% of companies in Healthcare sector

High & Low

All-time High

$1.07 B
DVA quarterly EBITDA is currently -35.05% below its historical high of $1.07 billion

3-Year Low

$442.52 M
DVA quarterly EBITDA is currently +57.06% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DVA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
DVA next earnings announcement is scheduled for Feb 13, 2025

OtherDVAprofitabilitymetrics:

Quarterly Revenue

$3.26 B
DVA quarterly revenue is $3.26 billion

Quarterly Net Income

$214.69 M
DVA quarterly net profit is $214.69 million

Quarterly EBIT

$508.02 M
DVA quarterly earnings before interest & taxes is $508.02 million

Quarterly EPS

$2.50
DVA quarterly earnings per share is $2.50

TTM EBITDA

$2.58 B
+$30.32 M+1.19%

September 30, 2024

Summary

Performance

3-Month Change

+1.19%

1-Year Change

+11.1%

3-Year Change

+11.1%

5-Year Change

+11.1%

DVA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.64%
DVA TTM EBITDA is higher than 96.64% of companies in Healthcare sector

High & Low

All-time High

$3.22 B
DVA TTM EBITDA is currently -19.95% below its historical high of $3.22 billion

3-Year Low

$2.02 B
DVA TTM EBITDA is currently +27.68% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
DVA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
DVA next earnings announcement is scheduled for Feb 13, 2025

OtherDVAprofitabilitymetrics:

TTM Revenue

$12.67 B
DVA TTM revenue is $12.67 billion

TTM Net Income

$827.68 M
DVA TTM net profit is $827.68 million

TTM EBIT

$1.83 B
DVA TTM earnings before interest & taxes is $1.83 billion

TTM EPS

$9.27
DVA TTM earnings per share is $9.27

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$2.32 B
DVA annual EBITDA is $2.32 billion

Annual Net Income

$691.53 M
DVA annual net profit is $691.53 million

Annual Interest Expense

$398.55 M
DVA annual interest expense is $398.55 million

Annual Income Tax

$220.12 M
DVA annual income tax is $220.12 million

Annual D&A

$745.44 M
DVA annual depreciation & amortization is $745.44 million

DVA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.9%+19.7%+11.1%
3 y3 years+3.0%+19.7%+11.1%
5 y5 years+9.1%+19.7%+11.1%

DVA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.6%+12.9%at high+57.1%at high+27.7%
5 y5-year-6.6%+12.9%at high+57.1%at high+27.7%
alltimeall time-15.8%>+9999.0%-35.0%+1319.3%-19.9%>+9999.0%

DaVita EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$695.03 M(+7.8%)
$2.58 B(+1.2%)
Jun 2024
-
$644.85 M(-2.0%)
$2.55 B(+2.5%)
Mar 2024
-
$658.29 M(+13.4%)
$2.49 B(+7.1%)
Dec 2023
$2.32 B(+12.9%)
$580.53 M(-12.7%)
$2.32 B(+6.3%)
Sep 2023
-
$664.71 M(+14.1%)
$2.18 B(+8.1%)
Jun 2023
-
$582.37 M(+18.0%)
$2.02 B(-1.0%)
Mar 2023
-
$493.47 M(+11.5%)
$2.04 B(-0.8%)
Dec 2022
$2.06 B(-17.2%)
$442.52 M(-11.7%)
$2.06 B(-5.5%)
Sep 2022
-
$501.30 M(-16.8%)
$2.18 B(-5.9%)
Jun 2022
-
$602.61 M(+18.3%)
$2.31 B(-3.1%)
Mar 2022
-
$509.47 M(-9.3%)
$2.38 B(-4.0%)
Dec 2021
$2.48 B(+10.3%)
$561.79 M(-11.9%)
$2.48 B(+0.5%)
Sep 2021
-
$637.75 M(-5.6%)
$2.47 B(+5.3%)
Jun 2021
-
$675.35 M(+10.8%)
$2.35 B(+4.4%)
Mar 2021
-
$609.47 M(+10.9%)
$2.25 B(-0.1%)
Dec 2020
$2.25 B(-0.1%)
$549.33 M(+6.9%)
$2.25 B(-3.6%)
Sep 2020
-
$513.88 M(-10.9%)
$2.34 B(-0.2%)
Jun 2020
-
$576.84 M(-5.9%)
$2.34 B(-1.3%)
Mar 2020
-
$612.76 M(-3.1%)
$2.37 B(+5.2%)
Dec 2019
$2.25 B(+6.0%)
$632.54 M(+22.0%)
$2.25 B(+4.2%)
Sep 2019
-
$518.29 M(-14.7%)
$2.16 B(+3.8%)
Jun 2019
-
$607.61 M(+22.5%)
$2.09 B(+1.0%)
Mar 2019
-
$495.98 M(-8.6%)
$2.06 B(-2.9%)
Dec 2018
$2.13 B(-18.4%)
$542.57 M(+23.6%)
$2.13 B(+10.5%)
Sep 2018
-
$439.05 M(-25.2%)
$1.92 B(-7.8%)
Jun 2018
-
$587.26 M(+5.2%)
$2.09 B(-0.4%)
Mar 2018
-
$558.07 M(+64.2%)
$2.10 B(-19.6%)
Dec 2017
$2.61 B(-5.4%)
$339.78 M(-43.6%)
$2.61 B(-7.5%)
Sep 2017
-
$601.97 M(+1.0%)
$2.82 B(-12.4%)
Jun 2017
-
$596.03 M(-44.3%)
$3.22 B(+2.7%)
Mar 2017
-
$1.07 B(+93.7%)
$3.14 B(+20.5%)
Dec 2016
$2.76 B(+59.0%)
$552.38 M(-44.9%)
$2.61 B(+7.2%)
Sep 2016
-
$1.00 B(+95.6%)
$2.43 B(+15.6%)
Jun 2016
-
$512.67 M(-4.6%)
$2.10 B(-3.7%)
Mar 2016
-
$537.22 M(+42.1%)
$2.18 B(+25.8%)
Dec 2015
$1.73 B(-24.9%)
$378.15 M(-43.9%)
$1.73 B(-11.6%)
Sep 2015
-
$673.91 M(+13.5%)
$1.96 B(+4.7%)
Jun 2015
-
$593.63 M(+566.3%)
$1.87 B(+3.3%)
Mar 2015
-
$89.10 M(-85.3%)
$1.81 B(-21.5%)
Dec 2014
$2.31 B(+10.9%)
$605.91 M(+3.5%)
$2.31 B(-0.9%)
Sep 2014
-
$585.49 M(+9.6%)
$2.33 B(+3.2%)
Jun 2014
-
$534.35 M(-8.7%)
$2.26 B(-4.9%)
Mar 2014
-
$585.50 M(-6.6%)
$2.38 B(+14.0%)
Dec 2013
$2.08 B(+27.5%)
$627.10 M(+22.4%)
$2.08 B(+7.2%)
Sep 2013
-
$512.19 M(-21.4%)
$1.94 B(+4.8%)
Jun 2013
-
$651.27 M(+122.0%)
$1.85 B(+21.3%)
Mar 2013
-
$293.37 M(-39.8%)
$1.53 B(-6.4%)
Dec 2012
$1.63 B(+14.6%)
$487.67 M(+15.5%)
$1.63 B(+3.8%)
Sep 2012
-
$422.29 M(+29.6%)
$1.57 B(+2.3%)
Jun 2012
-
$325.91 M(-18.1%)
$1.54 B(+0.9%)
Mar 2012
-
$397.90 M(-7.0%)
$1.52 B(+7.0%)
Dec 2011
$1.43 B(+23.1%)
$427.82 M(+10.5%)
$1.43 B(+14.9%)
Sep 2011
-
$387.33 M(+24.3%)
$1.24 B(+6.1%)
Jun 2011
-
$311.65 M(+4.5%)
$1.17 B(+1.2%)
Mar 2011
-
$298.21 M(+22.5%)
$1.15 B(-0.2%)
Dec 2010
$1.16 B(-1.3%)
$243.41 M(-23.0%)
$1.16 B(-4.4%)
Sep 2010
-
$315.99 M(+6.3%)
$1.21 B(+1.1%)
Jun 2010
-
$297.33 M(-1.2%)
$1.20 B(+0.2%)
Mar 2010
-
$300.96 M(+1.6%)
$1.20 B(+1.9%)
Dec 2009
$1.17 B
$296.26 M(-2.2%)
$1.17 B(-2.6%)
Sep 2009
-
$302.81 M(+2.5%)
$1.20 B(+3.4%)
DateAnnualQuarterlyTTM
Jun 2009
-
$295.41 M(+6.1%)
$1.16 B(+1.8%)
Mar 2009
-
$278.48 M(-15.0%)
$1.14 B(+1.3%)
Dec 2008
$1.10 B(+4.0%)
$327.59 M(+24.6%)
$1.13 B(+7.7%)
Sep 2008
-
$262.85 M(-4.2%)
$1.05 B(+0.1%)
Jun 2008
-
$274.31 M(+4.1%)
$1.05 B(-3.1%)
Mar 2008
-
$263.45 M(+6.8%)
$1.08 B(+2.3%)
Dec 2007
$1.06 B(+15.7%)
$246.66 M(-5.7%)
$1.06 B(+1.2%)
Sep 2007
-
$261.64 M(-15.1%)
$1.04 B(+0.0%)
Jun 2007
-
$308.27 M(+28.9%)
$1.04 B(+10.0%)
Mar 2007
-
$239.11 M(+2.3%)
$947.87 M(+3.9%)
Dec 2006
$912.73 M(+56.0%)
$233.72 M(-10.6%)
$912.73 M(+3.7%)
Sep 2006
-
$261.57 M(+22.5%)
$880.44 M(+17.3%)
Jun 2006
-
$213.47 M(+4.7%)
$750.53 M(+12.8%)
Mar 2006
-
$203.97 M(+1.3%)
$665.36 M(+13.7%)
Dec 2005
$585.09 M(+25.1%)
$201.43 M(+53.0%)
$585.10 M(+21.1%)
Sep 2005
-
$131.67 M(+2.6%)
$483.06 M(-0.5%)
Jun 2005
-
$128.29 M(+3.7%)
$485.29 M(+2.3%)
Mar 2005
-
$123.71 M(+24.5%)
$474.40 M(+1.4%)
Dec 2004
$467.79 M(+7.6%)
$99.39 M(-25.8%)
$467.79 M(-4.7%)
Sep 2004
-
$133.91 M(+14.1%)
$490.98 M(+4.1%)
Jun 2004
-
$117.39 M(+0.2%)
$471.62 M(+3.7%)
Mar 2004
-
$117.10 M(-4.5%)
$454.94 M(+4.7%)
Dec 2003
$434.62 M(-3.1%)
$122.57 M(+7.0%)
$434.62 M(-1.6%)
Sep 2003
-
$114.55 M(+13.7%)
$441.62 M(-2.9%)
Jun 2003
-
$100.72 M(+4.1%)
$454.66 M(+0.9%)
Mar 2003
-
$96.78 M(-25.3%)
$450.55 M(-61.1%)
Dec 2002
$448.49 M(+7.8%)
$129.57 M(+1.5%)
$1.16 B(+3.1%)
Sep 2002
-
$127.59 M(+32.1%)
$1.12 B(+0.4%)
Jun 2002
-
$96.61 M(-88.0%)
$1.12 B(-0.0%)
Mar 2002
-
$804.99 M(+754.1%)
$1.12 B(+169.1%)
Dec 2001
$416.07 M(+43.0%)
$94.25 M(-23.5%)
$416.07 M(+3.8%)
Sep 2001
-
$123.15 M(+26.9%)
$400.90 M(+13.1%)
Jun 2001
-
$97.06 M(-4.5%)
$354.58 M(+9.3%)
Mar 2001
-
$101.61 M(+28.5%)
$324.46 M(+11.5%)
Dec 2000
$290.88 M(+54.5%)
$79.08 M(+2.9%)
$290.88 M(+37.5%)
Sep 2000
-
$76.83 M(+14.8%)
$211.60 M(+5.0%)
Jun 2000
-
$66.93 M(-1.6%)
$201.47 M(+16.7%)
Mar 2000
-
$68.03 M(<-9900.0%)
$172.64 M(-14.3%)
Dec 1999
$188.30 M(-37.9%)
-$196.00 K(-100.3%)
$201.50 M(-23.4%)
Sep 1999
-
$66.70 M(+75.1%)
$263.00 M(-8.6%)
Jun 1999
-
$38.10 M(-60.7%)
$287.80 M(-12.8%)
Mar 1999
-
$96.90 M(+58.1%)
$330.00 M(+9.0%)
Dec 1998
$303.40 M(+83.7%)
$61.30 M(-33.0%)
$302.80 M(+7.3%)
Sep 1998
-
$91.50 M(+13.9%)
$282.10 M(+12.8%)
Jun 1998
-
$80.30 M(+15.2%)
$250.00 M(+28.3%)
Mar 1998
-
$69.70 M(+71.7%)
$194.80 M(+33.1%)
Dec 1997
$165.20 M(+56.3%)
$40.60 M(-31.6%)
$146.40 M(-12.3%)
Sep 1997
-
$59.40 M(+136.7%)
$166.90 M(+33.6%)
Jun 1997
-
$25.10 M(+17.8%)
$124.90 M(+8.6%)
Mar 1997
-
$21.30 M(-65.1%)
$115.00 M(+8.8%)
Dec 1996
$105.70 M(+218.4%)
$61.10 M(+251.1%)
$105.70 M(+92.2%)
Sep 1996
-
$17.40 M(+14.5%)
$55.00 M(+17.5%)
Jun 1996
-
$15.20 M(+26.7%)
$46.80 M(-284.3%)
Mar 1996
-
$12.00 M(+15.4%)
-$25.40 M(+101.6%)
Dec 1995
$33.20 M(+51.6%)
-
-
Nov 1995
-
$10.40 M(+13.0%)
-$12.60 M(-841.2%)
Aug 1995
-
$9.20 M(-116.1%)
$1.70 M(-90.1%)
May 1995
-
-$57.00 M(-329.8%)
$17.20 M(-76.8%)
May 1995
$21.90 M
-
-
Feb 1995
-
$24.80 M(+0.4%)
$74.20 M(+50.2%)
Nov 1994
-
$24.70 M(0.0%)
$49.40 M(+100.0%)
Aug 1994
-
$24.70 M
$24.70 M

FAQ

  • What is DaVita annual EBITDA?
  • What is the all time high annual EBITDA for DaVita?
  • What is DaVita annual EBITDA year-on-year change?
  • What is DaVita quarterly EBITDA?
  • What is the all time high quarterly EBITDA for DaVita?
  • What is DaVita quarterly EBITDA year-on-year change?
  • What is DaVita TTM EBITDA?
  • What is the all time high TTM EBITDA for DaVita?
  • What is DaVita TTM EBITDA year-on-year change?

What is DaVita annual EBITDA?

The current annual EBITDA of DVA is $2.32 B

What is the all time high annual EBITDA for DaVita?

DaVita all-time high annual EBITDA is $2.76 B

What is DaVita annual EBITDA year-on-year change?

Over the past year, DVA annual EBITDA has changed by +$265.19 M (+12.90%)

What is DaVita quarterly EBITDA?

The current quarterly EBITDA of DVA is $695.03 M

What is the all time high quarterly EBITDA for DaVita?

DaVita all-time high quarterly EBITDA is $1.07 B

What is DaVita quarterly EBITDA year-on-year change?

Over the past year, DVA quarterly EBITDA has changed by +$114.50 M (+19.72%)

What is DaVita TTM EBITDA?

The current TTM EBITDA of DVA is $2.58 B

What is the all time high TTM EBITDA for DaVita?

DaVita all-time high TTM EBITDA is $3.22 B

What is DaVita TTM EBITDA year-on-year change?

Over the past year, DVA TTM EBITDA has changed by +$257.61 M (+11.10%)